ChemotherapyFDA-approvedFirst-line
Carboplatin
How it works
Damages the DNA of cancer cells, preventing them from growing and dividing.
Cancer types
Lung Cancer— All patients
Efficacy
Carboplatin has been shown to improve survival rates and delay disease progression in ovarian cancer patients.
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Testing Sacituzumab Tirumotecan in Advanced Lung Cancer | Lung Cancer | phase-3 | — | Source → |
| Testing a Combination Treatment for Early-stage Triple-negative Breast Cancer | Breast Cancer | phase-2 | — | Source → |
| Researchers Investigate New Ovarian Cancer Treatment Options | Ovarian Cancer | lab-study | — | Source → |
| LINC00963 May Help Overcome Chemoresistance in Pancreatic Cancer | Pancreatic Cancer | lab-study | — | Source → |
| Combining Medications Improves Lung Cancer Treatment for Some Patients | Lung Cancer | phase-3 | Combination therapy significantly prolonged median progression-free survival compared with monotherapy (19.78 vs 16.53 months; hazard ratio, 0.58; 95% confidence interval, 0.34-0.97). | Source → |
| Adding Carboplatin to Chemotherapy Improves Outcomes in Early-Stage Triple-Negative Breast Cancer | Breast Cancer | phase-3 | Adding carboplatin significantly improved disease-free survival (HR, 0.66; [95% CI, 0.44 to 0.97]; p = .034), distant disease-free survival (HR, 0.61 [95% CI, 0.38 to 0.98]; p = .040), and overall survival (HR, 0.39 [95% CI, 0.16 to 0.94]; p = .029). | Source → |
| Testing Neoadjuvant Carboplatin for High-Risk Prostate Cancer with BRCA Mutations | Prostate Cancer | phase-2 | — | Source → |
| Combining medications to treat advanced breast and ovarian cancer | Ovarian Cancer | phase-1 | There were 3 major responses (1CR, 2PR) at DL1, and 1 CR at DL-1. | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.